This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonzalez, A. M. Articles by Baird, A. Search for Related Content PubMed PubMed Citation Articles by Gonzalez, A. M. Articles by Baird, A.

American Journal of Pathology, Vol 141, 661-671, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Basic fibroblast growth factor in Dupuytren's contracture

AM Gonzalez, M Buscaglia, R Fox, A Isacchi, P Sarmientos, J Farris, M Ong, D Martineau, DA Lappi and A Baird
Department of Molecular and Cellular Growth Biology, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.

Lesions excised from nine patients undergoing surgery for Dupuytren's contracture (DC) and three normal fascia were examined for the presence of the angiogenic protein basic fibroblast growth factor (basic FGF). Endothelial cell proliferation assays established basic FGF-like activity in extracts of DC. Western blotting confirmed the presence of an 18,000-dalton protein which was localized in the lesions by immunohistochemical staining. All of the cells implicated in the progression of the disease (endothelial cells, fibroblasts, and myofibroblasts) contain the growth factor. Endothelial cells within the narrowed or occluded vessels, as well as fibroblasts surrounding these vessels, stained intensely positive. In situ hybridization using an antisense probe for human basic FGF and its receptor's (FGFR-1) mRNA established the major difference between normal and DC tissues: their levels are significantly higher than in the normal tissues. Thus the cells in DC also express both basic FGF and FGFR-1, suggesting a potential autocrine/paracrine role for basic FGF in the pathogenesis of DC. This finding is thus the first description of a nontumoral proliferative disease that can be directly associated with increased basic FGF mRNA. The possibility that therapies can be developed on the basis that basic FGF and its receptor are expressed in DC is discussed.

This article has been cited by other articles:

				A. M. P. FITZGERALD, J. J. R. KIRKPATRICK, and I. L. NAYLOR Dupuytren's Disease: The way forward? J Hand Surg Eur Vol., August 1, 1999; 24(4): 395 - 399. [Abstract] [PDF]

				M A Hull, J L Brough, D G Powe, G I Carter, D Jenkins, and C J Hawkey Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa Gut, October 1, 1998; 43(4): 525 - 536. [Abstract] [Full Text] [PDF]